Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2013 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm's Canal Microstent in Combination Cataract and Glaucoma Surgery.
Ophthalmology. 2022 Jul;129(7):742-751. doi: 10.1016/j.ophtha.2022.02.021. Epub 2022 Feb 23.
Ophthalmology. 2022.
PMID: 35218867
Clinical Trial.
Three-Year Findings of the HORIZON Trial: A Schlemm Canal Microstent for Pressure Reduction in Primary Open-Angle Glaucoma and Cataract.
Ahmed IIK, Rhee DJ, Jones J, Singh IP, Radcliffe N, Gazzard G, Samuelson TW, Ong J, Singh K; HORIZON Investigators.
Ahmed IIK, et al.
Ophthalmology. 2021 Jun;128(6):857-865. doi: 10.1016/j.ophtha.2020.11.004. Epub 2020 Nov 6.
Ophthalmology. 2021.
PMID: 33166551
Clinical Trial.
Item in Clipboard
A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract: The HORIZON Study.
Samuelson TW, Chang DF, Marquis R, Flowers B, Lim KS, Ahmed IIK, Jampel HD, Aung T, Crandall AS, Singh K; HORIZON Investigators.
Samuelson TW, et al.
Ophthalmology. 2019 Jan;126(1):29-37. doi: 10.1016/j.ophtha.2018.05.012. Epub 2018 Jun 23.
Ophthalmology. 2019.
PMID: 29945799
Clinical Trial.
Item in Clipboard
A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.
HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network.
HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network.
JAMA Neurol. 2013 Jan;70(1):25-33. doi: 10.1001/2013.jamaneurol.382.
JAMA Neurol. 2013.
PMID: 23108692
Clinical Trial.
Item in Clipboard
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN; HORIZON investigators.
Reid DM, et al.
Lancet. 2009 Apr 11;373(9671):1253-63. doi: 10.1016/S0140-6736(09)60250-6.
Lancet. 2009.
PMID: 19362675
Clinical Trial.
Item in Clipboard
Cite
Cite